You are here

USG awards $500 million to companies for developing spray, pill COVID vaccines

Primary tabs

Mon, 2024-06-17 17:56 — mike kraft

Feds award $500 million for developing spray, pill COVID vaccines The vast majority of funds—up to $453 million—goes to Vaxart of San Francisco for developing an oral pill vaccine candidate. CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

Medical - global

- Private group -

Log in or register to post comments

Page loaded in 0.466 seconds.